Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors

OBJECTIVE: To focus on the potential beneficial effects of the pleiotropic effects of dipeptidyl peptidase-4 inhibitors (DPP4is) on attenuating progression of diabetic kidney disease in reducing the long-term effect of the acute kidney injury (AKI) to chronic kidney disease (CKD) transition. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng-Yi, Wu, Vin-Cent, Lin, Cheng-Jui, Lin, Chih-Sheng, Pan, Chi-Feng, Chen, Han-Hsiang, Lin, Yu-Feng, Huang, Tao-Min, Chen, Likwang, Wu, Chih-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126857/
https://www.ncbi.nlm.nih.gov/pubmed/30343892
http://dx.doi.org/10.1016/j.mayocp.2018.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126857/
https://www.ncbi.nlm.nih.gov/pubmed/30343892
http://dx.doi.org/10.1016/j.mayocp.2018.06.023

Ejemplares similares